| Home > Publications Database > Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease > Access to Fulltext |
DZNE-2024-00567
|
|||||||
| version 1 |
| ||||||
| Restricted | |||||||
DZNE-2024-00567 SUP1
|
|||||||
| version 1 |
| ||||||
| Restricted | |||||||
DZNE-2024-00567 SUP2
|
|||||||
| version 1 |
| ||||||
| Restricted | |||||||
DZNE-2024-00567 SUP3
|
|||||||
| version 1 |
| ||||||